Johnson, B. (2022) “Epidermal Growth Factor Receptor Inhibitor Treatment Timing does not Impact Survival in Stage 4 Colon Cancer Treatment: A Retrospective Study: EGFR Inhibitor Treatment Line Outcomes”, Kansas Journal of Medicine, 15(2), pp. 273–277. doi:10.17161/kjm.vol15.15975.